PATENT CLAIM ANALYSIS

Application Number: 15954541
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment.

Claim (Index 42):
The method of  claim 40 , wherein the cells of said tumor further comprise nucleic acid that encodes an L858R EGFR protein mutation.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.58824
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13537739', '13972527', '13095362', '12272321', '11145566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8117194961586759
- 35 USC 102 Novelty (BERT): 0.5553464435128322
- Combined Prediction Score: 0.7860821908940915
- Mean Citation Score: 431.07034
- Max Citation Score: 439.63995
- Similarity Product: 321.37819501817825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test